Abbott Price Target: 140
Abbott delivers double-digit underlying organic growth in 2021 and sees >6bn in COVID-19 Revenues
Abbott has high exposure to emerging markets and consumer-directed businesses, driving the potential for sustainable double-digit earnings growth
Leverage opportunities are visible across multiple business segments including Nutrition, Diagnostics, and EPD
Abbott has high exposure to emerging markets and consumer-directed businesses, driving the potential for sustainable double-digit earnings growth
Leverage opportunities are visible across multiple business segments including Nutrition, Diagnostics, and EPD
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.